πŸ‡ΊπŸ‡Έ FDA
Patent

US 12384820

Griffithsin mutants

granted A61KA61K38/00A61K38/16

Quick answer

US patent 12384820 (Griffithsin mutants) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K38/16